Pérez, Ana Belén <br/><br/>
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world.  [electronic resource] 

 -  Journal of hepatology  11 2019 
 - 876-888 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0641 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2019.06.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anilides--therapeutic use<br/>Antiviral Agents--pharmacology<br/>Benzimidazoles--therapeutic use<br/>Carbamates--therapeutic use<br/>Cyclopropanes--therapeutic use<br/>Drug Resistance, Viral--genetics<br/>Drug Therapy, Combination<br/>Female<br/>Fluorenes--therapeutic use<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C--drug therapy<br/>Humans<br/>Imidazoles--therapeutic use<br/>Lactams, Macrocyclic--therapeutic use<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Prospective Studies<br/>Pyrrolidines<br/>Retreatment<br/>Ribavirin--therapeutic use<br/>Ritonavir--therapeutic use<br/>Sofosbuvir--therapeutic use<br/>Spain--epidemiology<br/>Sulfonamides--therapeutic use<br/>Sustained Virologic Response<br/>Valine--analogs & derivatives<br/>Viral Nonstructural Proteins--antagonists & inhibitors